The BioScience Ventures Group (BSVG) is an association of experienced business angels focused exclusively on investments in early-stage life-science companies. Investment size varies from 0.2 to 0.5 Mio. Euro per investment round.

BSVG consists furthermore of an experienced team with medical and pharmacological background specialized in drug development, the design of preclinical and clinical studies especially in the field of Biologics as for example antibodies or proteins.

Therefore BSVG succeeds in increasing the efficiency of its investments and to reduce development costs. In addition the team has broad and long experience within the investment business.